drugset / Trial / NCT06093672
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
RandomizedParallel-groupSingle-blindTreatment
Summary
The goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients.
Timeline
- Start
- 2024-03-26
- Primary completion
- 2026-07
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Givinostat | Small molecule | 50 mg | Oral |
| Comparator | Hydroxyurea | Other / unclassified | 500 mg | Oral |